메뉴 건너뛰기




Volumn 14, Issue 2, 2007, Pages 223-232

Possible effects of early treatments of Hsp90 inhibitors on preventing the evolution of drug resistance to other anti-cancer drugs

Author keywords

17 AAG; Apoptosis; Cancer; Drug resistance; Geldanamycin (GA); Hsp60; IC50

Indexed keywords

17 (DIMETHYLAMINOETHYLAMINO) 17 DEMETHOXYGELDANAMYCIN; 17 ALLYLALAMINODEMETHOXYGELDANAMYCIN; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 [N (2 HYDROXYETHYL) N [2 (3 INDOLYL)ETHYL]AMINOMETHYL]CINNAMOHYDROXAMIC ACID; 6 (2,6 DICHLOROPHENYL) 2 (4 FLUORO 3 METHYLANILINO) 8 METHYL 8H PYRIDO[2,3 D]PYRIMIDIN 7 ONE; 7 HYDROXYSTAUROSPORINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BORTEZOMIB; BUTYRIC ACID; CHAPERONE; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FUNGICIDE; GELDANAMYCIN; GEMCITABINE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; IMATINIB; MIDOSTAURIN; MITOMYCIN C; PACLITAXEL; RADICICOL; TAMOXIFEN; TRASTUZUMAB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; VORINOSTAT;

EID: 33846000300     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986707779313372     Document Type: Review
Times cited : (19)

References (102)
  • 23
    • 25844450827 scopus 로고    scopus 로고
    • Heitman, J. Science 2005, 309, 2175.
    • (2005) Science , vol.309 , pp. 2175
    • Heitman, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.